(Medical Xpress)—The largest protein known to exist in the human body functions as a molecular spring, and University of Arizona researchers are gaining new insights into its role in heart disease.
3 / 5 (1) |
0
Serelaxin may be more effective for relieving dyspnea in heart failure with preserved ejection fraction (HFpEF) than reduced (HFrEF) during the first 24 hours, according to results from RELAX-AHF presented in today's late ...
not rated yet |
0
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...
5 / 5 (7) |
6
A major factor in the advance of heart disease is the death of heart tissue, a process that a team of scientists at Temple University School of Medicine's (TUSM) Center for Translational Medicine think could be prevented ...
5 / 5 (1) |
0
|
(Medical Xpress)—University of Otago researchers have discovered a potential new tool to help doctors in emergency departments quickly and accurately diagnose patients with heart failure and pneumonia.
not rated yet |
0
A UCLA study shows that heart failure medications recommended by national guidelines are highly cost effective in saving lives and may also provide savings to the health care system.
not rated yet |
0
|
Among patients with heart failure with preserved ejection fraction (a measure of heart function), administration of sildenafil (commercially known as Viagra) for 24 weeks, compared with placebo, did not result in significant ...
not rated yet |
0
Researchers from Cleveland Clinic and Sweden-based Sahlgrenska University Hospital have found that a commonly used drug to treat anemia in heart failure patients –darbepoetin alfa – does not improve patients' health, ...
not rated yet |
0
|
Even minor weight loss is associated with worse health outcomes among patients implanted with a certain type of defibrillator known as cardiac resynchronization therapy with defibrillator (CRT-D), according to research being ...
not rated yet |
0
Among patients with heart failure with preserved ejection fraction, long-term treatment with the medication spironolactone improved left ventricular diastolic function but did not affect maximal exercise capacity, patient ...
not rated yet |
0
|
Medical literature long has touted the benefits of omega-3 fatty acids for the heart. But until now, researchers have not studied the potential benefit for people on hemodialysis, who are among the highest-risk patients for ...
not rated yet |
0
Despite a substantial increase in the number of people suffering the debilitating and often deadly effects of heart failure, treatments for the condition have not advanced significantly for at least 10 years. An analysis ...
5 / 5 (1) |
0
|
(HealthDay)—Hospital nurses with good work environments who are caring for fewer patients have significantly fewer elderly Medicare patients with heart failure, acute myocardial infarction (MI), and pneumonia ...
not rated yet |
0
Digoxin, a drug widely used to treat heart disease, increases the possibility of death when used by patients with a common heart rhythm problem − atrial fibrillation (AF), according to new study findings by University of ...
not rated yet |
0
|
(HealthDay)—Pilates exercises may be a beneficial adjunctive treatment for patients with heart failure, offering functional capacity improvements, according to a study published in the December issue of ...
not rated yet |
0
